Mark Pastreich is Director at REPRO MED SYSTEMS INC (REPR). They have made 1 open-market trade across 1 company since 2012, most recently 2016-02-29.
CIK 0001521736
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $392.0M since 2012, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| REPR | 14,566 | $58K |
Shares reported on the most recent Form 4, priced at the 2016-03-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| REPR | BUY | 2012-03-20 | 2012-03-21 | $9800.00 | $392.0M | N/A | +2.1% | +2.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.